GMAB — Genmab A/S

Ownership history in FLOW TRADERS U.S. LLC  ·  1 quarter on record

This page tracks every 13F SEC filing in which FLOW TRADERS U.S. LLC reported a position in Genmab A/S (GMAB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2025 Q3)
Avg. % of fund
0.01%
First filed
2025 Q3
Last filed
2025 Q3
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 INITIATED 7,931 — — 0.01% $243K $30.67
% of Fund (quarterly)    GMAB price (monthly, adj. close)

Other funds also holding GMAB

As of 2025 Q4 — sorted by position size

Paradigm Biocapital Advisors LP 3Y 5.53% Orbis Allan Gray Ltd 3Y 7Y 1.86% AIMZ Investment Advisors, LLC 3Y 7Y 1.44% Private Wealth Advisors, LLC 3Y 1.3% Terra Nova Asset Management LLC 3Y 7Y 1.23% HARDING LOEVNER LP 3Y 7Y 0.91% Avidity Partners Management LP 3Y 0.82% SUPERSTRING CAPITAL MANAGEMENT LP 0.48% VIRTUS ADVISERS, LLC 3Y 7Y 0.4% Perpetual Ltd 3Y 7Y 0.37%
← Back to FLOW TRADERS U.S. LLC Holdings